-
environment. The lab follows Standard Operating Procedures and cGLP (current Good Laboratory Practice) and/or cGMP (current Good Manufacturing Practices). You will be recognized as a technical expert and a
-
compound concentration, detect the presence of anti-drug antibody and neutralizing anti-product antibody activity utilizing various platforms in a regulated (GLP, GCP) environment against challenging
-
, technical modeling and simulation expert in a preclinical drug discovery environment Committed to sharing technical expertise and the development of self and others Preferred Qualifications: Experience in
-
results Presentation of results within a multidisciplinary team environment. Ensure appropriate use of animals in compliance with all regulatory requirements and internal standards. BASIC QUALIFICATIONS
-
environment on several research programs simultaneously with aggressive timelines. Able to work with limited daily supervision. Nice-to-Have Hands-on experience in flow cytometry Drug discovery experience
-
of applying knowledge of principles, concepts, and practices of the discipline will make you a critical member of the team. You are proactive in contributing to all team discussions and creating an environment
-
for results and generate innovative solutions with minimum supervision. Applicants should be self-motivated, organized, capable of working independently, and in a collaborative environment. The successful
-
multidisciplinary teams Ability to work independently to achieve objectives, and collaboratively in a team-oriented environment under timeline commitments, often necessitating workload prioritization Nice-to-Have
-
attention to detail and ability to collaborate and work in team environment. Proficiency with Microsoft Office applications and relevant scientific software. Effective verbal and written communication skills
-
colleagues the flexibility and tools they need. The Primary Pharmacology Group offers a collegial and supportive environment for colleagues, with a culture encouraging openness, innovation, and ownership